SOME MORPHOMETRIC EVIDENCE OF HEPATOPROTECTIVE EFFECTS OF (+)-CYANIDANOL-3

被引:8
作者
VARGA, M [1 ]
BURIS, L [1 ]
机构
[1] UNIV FLORIDA, J HILLIS MILLER HLTH CTR, CTR DRUG DESIGN & DELIVERY, COLL PHARM, GAINESVILLE, FL 32610 USA
关键词
D O I
10.1016/0091-3057(89)90380-8
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
引用
收藏
页码:523 / 526
页数:4
相关论文
共 50 条
[41]   POSSIBLE ANTI-ENDOTOXIN ACTIVITY OF (+)-CYANIDANOL-3 IN EXPERIMENTAL HEPATITIS IN THE RAT [J].
SCEVOLA, D ;
MAGLIULO, E ;
BARBARINI, G ;
MARONE, P ;
FILICE, C ;
CARNEVALE, G ;
MERONI, V .
HEPATO-GASTROENTEROLOGY, 1982, 29 (05) :178-182
[42]   INHIBITION OF CBRCL3-INDUCED LIPID PEROXIDATION IN RATS INVIVO BY (+)-CYANIDANOL-3 [J].
KOSTERALBRECHT, D ;
KOSTER, U ;
KAPPUS, H ;
REMMER, H .
TOXICOLOGY LETTERS, 1979, 3 (06) :363-368
[43]   STABILIZATION OF COLLAGEN THROUGH (+)-CYANIDANOL-3 - A POSSIBILITY FOR THERAPY OF CONNECTIVE TISSUES DISEASES [J].
PONTZ, BF ;
MULLER, PK .
JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY, 1982, 20 (09) :689-689
[44]   CHANGES IN BILIRUBIN TRANSPORT ACROSS THE LIVER BY THE FLAVONOIDS (+)-CYANIDANOL-3 AND PALMITOYL-CATECHIN [J].
RICCI, GL ;
BALDASSARRE, V ;
LONGO, G ;
ZANNINELLI, G .
ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1986, 36-1 (04) :691-694
[45]   IMMUNOHEMATOLOGICAL INVESTIGATIONS ON THE CONNECTION BETWEEN THE ADMINISTRATION OF (+)-CYANIDANOL-3 (CATERGEN) AND HEMOLYTIC-ANEMIA [J].
PAUSCH, V ;
GOBEL, J .
WIENER MEDIZINISCHE WOCHENSCHRIFT, 1983, 133 (21) :559-565
[46]   THE BILIARY-EXCRETION OF (+)-CYANIDANOL-3 ((+)-CATECHIN) IN NORMAL AND GALACTOSAMINE-HEPATITIS RATS [J].
SHAW, IC ;
GRIFFITHS, LA .
TOXICOLOGY LETTERS, 1980, :178-178
[47]   RESULTS OF A PROSPECTIVE DOUBLEBLIND STUDY WITH (+)-CYANIDANOL-3 AGAINST PLACEBO IN ACUTE VIRUS HEPATITIS [J].
SCHIMMELPFENNIG, W ;
RENGER, F ;
BAUMGARTEN, R ;
FENGLER, JD ;
PELZ, W ;
KALLER, B .
DEUTSCHE GESUNDHEITSWESEN-ZEITSCHRIFT FUR KLINISCHE MEDIZIN, 1984, 39 (33) :1290-1294
[48]   EPIDERMOLYSIS BULLOSA DYSTROPHICA (HOLLOPEAU-SIEMENS) - PRELIMINARY THERAPEUTIC TRIAL WITH (+)-CYANIDANOL-3 [J].
SCHURIG, V ;
LANDTHALER, M ;
BRAUNFALCO, O ;
KRIEG, T .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 1985, 277 (05) :415-416
[49]   DIFFERENTIAL RESPONSE OF PRIMARY CULTURES OF HUMAN AND RAT HEPATOCYTES TO AFLATOXIN B1-INDUCED CYTO-TOXICITY AND PROTECTION BY THE HEPATOPROTECTIVE AGENT (+)-CYANIDANOL-3 [J].
BEGUE, JM ;
BAFFET, G ;
CAMPION, JP ;
GUILLOUZO, A .
BIOLOGY OF THE CELL, 1988, 63 (03) :327-333
[50]   ANTIOXIDANT PROPERTIES OF THE FLAVONOIDS SILYBIN AND (+)-CYANIDANOL-3 - COMPARISON WITH BUTYLATED HYDROXYANISOLE AND BUTYLATED HYDROXYTOLUENE [J].
VALENZUELA, A ;
GUERRA, R ;
VIDELA, LA .
PLANTA MEDICA, 1986, (06) :438-440